features: Non-Hodgkin Lymphoma
Non-covalent BTK inhibitor LOXO-305 shows promising results in advanced B-cell malignancies
Bruton’s tyrosine kinase (BTK) plays an essential role in the B-cell antigen receptor signaling pathway and is required for the…
The Lymphoma Sessions: UK post-ASH 2020 discussion
A session with UK experts Graham Collins and Wendy Osborne, who discuss the key lymphoma highlights presented at ASH 2020.
The Lymphoma Sessions: post-ASH 2020 roundtable discussion
A session with experts Stephen Ansell and Graham Collins, who discuss the latest lymphoma updates from ASH 2020.
Radioimmunotherapy agent improves progression-free survival of NHL patients in real-world setting
A study presented during the 2020 American Society of Clinical Oncology and Society for Immunotherapy of Cancer Clinical Immuno-Oncology Symposium,…
Microbiota diversity can predict mortality in patients undergoing allo-HSCT
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an effective and curative therapy for a large number of hematologic malignancies. Adverse…
The REAL classification of lymphoma
Twenty-five years ago, almost to the day, there was a paradigm shift in the classification of lymphoma.